ReviewCardiovascular endocrinology & metabolism2026
Intermittent fasting in diabetic retinopathy: microbiome modulation, mechanisms, and clinical insights.
Review in Cardiovascular endocrinology & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intermittent fasting, a nonpharmacological approach, shows promise for controlling diabetic retinopathy but lacks concrete human evidence directly associating intermittent fasting with eye responses. This review highlights preclinical research insights about intermittent fasting and integrates emerging insights on intermittent fasting and its role as a complementary and alternative therapy with conventional diabetic retinopathy therapies. Animal models emphasize that intermittent fasting exhibits multimodal retinal neuroprotective functions and benefits primarily based on enhancing insulin and glucose metabolism, improving retinal mitophagy and mitochondrial functions, and reducing retinal oxidative and inflammation stress. Moreover, alternate-day fasting, 5:2 dietary formulas, and time-restricted eating plans have shown efficacy against acellular capillaries within db/db mice retinas. Simultaneously, intermittent fasting alters retinal gut microbial and bile metabolite responses and thus endorses a gut and eye relationship. These preclinical and emerging research insights thus project intermittent fasting and retinal therapies routed via intermittent fasting and bile acids modulation as retinal supportive and adjuvant therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.